JP2005538126A - 耳鳴の処置のためのカルボキサミドの使用 - Google Patents

耳鳴の処置のためのカルボキサミドの使用 Download PDF

Info

Publication number
JP2005538126A
JP2005538126A JP2004526887A JP2004526887A JP2005538126A JP 2005538126 A JP2005538126 A JP 2005538126A JP 2004526887 A JP2004526887 A JP 2004526887A JP 2004526887 A JP2004526887 A JP 2004526887A JP 2005538126 A JP2005538126 A JP 2005538126A
Authority
JP
Japan
Prior art keywords
formula
tinnitus
compound
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004526887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538126A5 (https=
Inventor
マルクス・シュムッツ
Original Assignee
ノバルティス アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0218244A external-priority patent/GB0218244D0/en
Priority claimed from GB0218243A external-priority patent/GB0218243D0/en
Application filed by ノバルティス アクチエンゲゼルシャフト filed Critical ノバルティス アクチエンゲゼルシャフト
Publication of JP2005538126A publication Critical patent/JP2005538126A/ja
Publication of JP2005538126A5 publication Critical patent/JP2005538126A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2004526887A 2002-08-06 2003-08-05 耳鳴の処置のためのカルボキサミドの使用 Pending JP2005538126A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0218244A GB0218244D0 (en) 2002-08-06 2002-08-06 Organic compounds
GB0218243A GB0218243D0 (en) 2002-08-06 2002-08-06 Organic compounds
PCT/EP2003/008669 WO2004014391A1 (en) 2002-08-06 2003-08-05 Use of carboxamides for the treatment of tinnitus

Publications (2)

Publication Number Publication Date
JP2005538126A true JP2005538126A (ja) 2005-12-15
JP2005538126A5 JP2005538126A5 (https=) 2006-09-21

Family

ID=31716915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004526887A Pending JP2005538126A (ja) 2002-08-06 2003-08-05 耳鳴の処置のためのカルボキサミドの使用

Country Status (8)

Country Link
US (1) US7465723B2 (https=)
EP (1) EP1528927A1 (https=)
JP (1) JP2005538126A (https=)
CN (1) CN1674909A (https=)
AU (1) AU2003266965A1 (https=)
BR (1) BR0313230A (https=)
CA (1) CA2494660A1 (https=)
WO (1) WO2004014391A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
EP1879590A1 (en) * 2005-05-06 2008-01-23 Portela & Ca., S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US9410427B2 (en) * 2012-06-05 2016-08-09 United Technologies Corporation Compressor power and torque transmitting hub
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032183A2 (en) * 1999-11-02 2001-05-10 Novartis Ag Pharmaceutical compositions comprising oxcarbazepine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL125244A (en) 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032183A2 (en) * 1999-11-02 2001-05-10 Novartis Ag Pharmaceutical compositions comprising oxcarbazepine

Also Published As

Publication number Publication date
BR0313230A (pt) 2005-07-12
EP1528927A1 (en) 2005-05-11
CA2494660A1 (en) 2004-02-19
CN1674909A (zh) 2005-09-28
WO2004014391A1 (en) 2004-02-19
US7465723B2 (en) 2008-12-16
US20060106009A1 (en) 2006-05-18
WO2004014391B1 (en) 2004-04-15
AU2003266965A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
JP4897679B2 (ja) インドロン誘導体、その製造方法及びその使用
JPH09505806A (ja) Ｎ−プロパルギル−１−アミノインダン、これらの塩、組成物、及びこれらの使用
PL184124B1 (pl) Zastosowanie (R)-enancjomeru N-propargilo-1-aminoindanu, lub soli oraz kompozycja farmaceutyczna zawierająca (R)-enancjomer N-propargilo-1-aminoindanu lub jego sól
US20100120746A1 (en) Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain
SK106798A3 (en) Novel cyclic amino acids as pharmaceutical agents
FR2680507A1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CN112930175A (zh) 治疗癫痫的方法
JP2005538126A (ja) 耳鳴の処置のためのカルボキサミドの使用
US12144788B2 (en) Visual cycle modulators
US20100063029A1 (en) Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
JPH10512252A (ja) １−（３，４−ジクロロベンジル）−２−メチルアミノインダンの鏡像異性体
JP2010533717A (ja) 覚醒を促進する方法
JP2003500466A (ja) 医薬としての融合多環式アミノ酸
US12234208B2 (en) 3,4-dihydroxy-n-(1′-benzyl-2′-hydroxyethyl)-2-methylpyridine chloride, and synthesis and use thereof
FR2888748A1 (fr) Composes neuroprotecteurs et compositions pharmaceutiques les comprenant
JP2001523659A (ja) 細胞外グルタミン酸濃度を低下させるための４位置換２−ピロリジノン誘導体
JP4914346B2 (ja) ベンズオキサゾロン誘導体、その調製方法及びその使用
CN100356923C (zh) S－10－羟基－10,11－二氢－卡马西平在制备药物组合物中的用途
EP0146443B1 (fr) (-)-1-(2-Fluorophényl)-2-tertiobutylamino-1-éthanol, utilisation en thérapeutique
WO1996031481A1 (en) Novel heterocyclic compounds
Stone Overview: Excitatory Amino Acids; Current Opinion in Therapeutic Patents June 1992
TW200845976A (en) Huperzine a compound and pharmaceutical composition comprising the same
MXPA05001534A (es) Uso terapeutico de derivados arilo de aminoacidos.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060802

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100420

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100921